Strategic Alliances, Partnerships & Collaborations Analysis – April 2018

The pace of deal making has picked up a bit, but deal volume remains relatively low on both the M&A and strategic alliance fronts. As usual, smaller molecular and genomics firms are supplying most of the energy; but after a frenetic 2017, the bigger players have toned it down. Here is an overview of the deals that did come down from mid-April to mid-May.

One deal making a big splash was LabCorp and Walgreens’ agreement to expand their consumer collaboration by opening 10 new LabCorp patient service centers within Walgreens stores in Florida. Last year, the companies opened five co-branded in-store locations providing specimen collection services, four in Colorado and one in North Carolina.

The Walgreens deal was only part of LabCorp’s busy month. In addition to inking the Covance sale noted above, the North Carolina-based diagnostics megafirm announced a new collaboration with The Recovery Platform designed to expand access to medication-assisted opioid recovery treatment. A week earlier, LabCorp inked a deal to become the primary reference lab for the Mount Sinai Health System, one of the largest and most prestigious health networks in the metropolitan New York City area.

Here’s a summary of the key diagnostic deals from mid-April to mid-May:

Close

EMAIL ADDRESS


PASSWORD
EMAIL ADDRESS

FIRST NAME

LAST NAME

TITLE

COMPANY

CITY / STATE

Try Premium Membership

(-0000g2)